A Study to Evaluate the Efficacy and Tolerability of Rizatriptan for Treatment of Acute Migraine in Children and Adolescents (MK-0462-082 AM7)

Migraine, Acute Clinical Trial

Official title:
A Worldwide, Randomized, Double Blind, Placebo-Controlled, Parallel Group Clinical Trial to Evaluate the Safety and Efficacy of Rizatriptan for the Acute Treatment of Migraine in Children and Adolescents

Status Completed

Clinical Trial Summary

This Clinical Trial evaluates the Safety and Efficacy of Rizatriptan for the Acute Treatment of Migraine in Children and Adolescents.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01001234
Study type	Interventional
Source	Organon and Co
Contact
Status	Completed
Phase	Phase 3
Start date	November 30, 2009
Completion date	April 21, 2011

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00792636` - A Study to Determine the Effect of Sumatriptan and Naproxen Sodium Combination Tablet, Sumatriptan Tablet, and Naproxen Sodium Tablet on Blood Pressure When Treating Migraine Headaches That Occur During a 6-month Period	Phase 4
Completed	`NCT00383162` - A Study of Combination Product (Sumatriptan Succinate and Naproxen Sodium) in Migraine Subjects Who Report Poor Response or Intolerance to Short Acting Triptans (Study 1 of 2)	Phase 3
Completed	`NCT00269022` - Use Of SB-705498 In The Acute Treatment Of Migraine	Phase 2
Completed	`NCT00573170` - TREXIMET® Versus Butalbital-containing Combination Medications for the Acute Treatment of Migraine in Adults	Phase 3